haimbaran

WALL STREET REVIEW

SP:SPX   S&P 500 Index
Summary of the day (the day was) by HAIM BARAN

Drops (we've already forgotten how it looks)
...... 0.35% -0.4% .....
The day started (in the morning) green contracts .. Talks about a trade agreement on the way ... looks promising ... and at 15:30, weak macro data was published ... and the market reversed downward .. The trading day opened at 0.4-5%. In the first half Today's indices have rebounded to very real declines .. We thought here is a strong market reversal blah blah blah .. and the market began to fold down to 0.6-7% ... at the last market corrects a bit .. the overall closing is likely the market needs such days, felt pretty tired in the last two days.

S & P declined 0.35% to 2775, supported at 2765, support 2760, 2740, 2720 resistance. 2790, 2800, and 2815-20.

The DOW fell 0.4% to 25850. Support 25450-500, 25000-50, 24800 resistance 26000, 26300 and the peak.

The NASDAQ fell 0.39% to 7459. Rounded during the trade to the 7480-5 area and retreated. Support 7400, 7200, 7000 resistance 7500, 7570, 7670.

Today the market has dropped slightly, but it is not bad, and on the other hand, this drop is even welcome (2740-S & P). The difficulty was very difficult to ignore.
At the moment, the market is ... 2740-2800 ... Let's give it the reins ... and we'll see where it will lead .. Break in here or there, and it's considered a new route... At the moment not exactly a region for the Lungis and Shorts have not exactly worked until now. In my opinion, a logical option at the moment (you can work point-specific things ....)

The share of LOPE rose 21.4%, DLPH rose 19.1%, CAR rose 17.1%, SPMS rose 9.7%, SPM rose 9.7%, ALB rose 7.8%, HTZ rose 7.6%, PEGA rose 7.5%, IART rose 7%, TTC rose 7% ... ..

Declined: CBLK stock fell 23.7%, UNIT continues to fall another 18.6%, VIPS fell 13.8%, INOV fell 12.7%, SATS fell 10%, GDOT dropped 10%, DPZ dropped 9.2% .....

Good night
S&P
NASDAQ
DOW
RUSSELL
.
.
For tracking
NIO
HEAR
BE
UXIN
I

VTVT(Dangerous)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.